Improving Symptoms and Outcomes in a 68 year-old woman with Symptomatic Systolic HF is organized by American College of Cardiology (ACC).

Date of Release: August 1, 2022
Term of Approval/Date of Expiration: July 31, 2025

Description:
Gain insights on the practical components of SGLT2is including patient selection, initiation, dosing, sequencing, and monitoring to successfully incorporate these agents into practice.

Learner Objectives:
Upon completion of this activity, you should be able to:
• Identify the clinical indications and key considerations for the selection of SGLT2 inhibitors for heart failure patients
• Establish a contemporary prescribing timeline including initiation, dosing, and monitoring of SGLT2 inhibitors?

Additional details will be posted as soon as information is available.